Insulet CFO leaves for 3M health spinoff
Wayde McMillan is the second high-profile medtech executive in recent months to join 3M.
Uncategorized
Warren, Jayapal call for closer scrutiny of UnitedHealth-Amedisys deal
The progressive lawmakers sent a letter Tuesday to top antitrust regulators urging heightened attention to the $3.3 billion transaction, which is currently under investigation by the Department of Justice.
Warren, Jayapal call for closer scrutiny of UnitedHealth-Amedisys deal Read More »
75,000 Kaiser Permanente workers begin striking as negotiations continue
Kaiser Permanente workers began striking at hundreds of locations this morning in the largest strike in the industry’s history after contract negotiations failed to produce a new agreement.
75,000 Kaiser Permanente workers begin striking as negotiations continue Read More »
Investors Fuel Fountain of Youth Research with Longevity Company Funding
The call to develop therapeutics that interfere with aging, helping people live not only longer but healthier lives, is increasing.
Investors Fuel Fountain of Youth Research with Longevity Company Funding Read More »
Aerium Therapeutics Advances Next Generation Antibodies to Protect Immunocompromised Persons Against COVID-19
Aerium Therapeutics Advances Next Generation Antibodies to Protect Immunocompromised Persons Against COVID-19.
Arcturus Therapeutics Joint Venture mRNA Manufacturing Partner, ARCALIS, Awarded Additional Financial Grants from Japanese Government
Arcturus Therapeutics Holdings Inc. announced today that ARCALIS, Arcturus’ manufacturing joint venture in Japan to support the production of mRNA vaccines and therapeutics, has been selected by the Japanese Ministry of Economy, Trade and Industry to receive additional financial support to construct a DNA template manufacturing facility along with new state-of-the-art equipment.
Day Zero Diagnostics Welcomes Microbiology and Genomic Researcher Dr. Patricia Simner to Advisory Board
Day Zero Diagnostics Inc. announced today the addition of Patricia (Trish) Simner , Ph.D., M.Sc., to its clinical advisory board.
Odyssey Therapeutics Appoints Jeremy Sokolove, MD as Chief Medical Officer
Odyssey Therapeutics, Inc. today announced the appointment of Jeremy Sokolove, M.D., as chief medical officer.
Odyssey Therapeutics Appoints Jeremy Sokolove, MD as Chief Medical Officer Read More »
Ankyra Therapeutics Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate ANK-101 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Solid Tumors
Ankyra Therapeutics Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate ANK-101 in Combination with KEYTRUDA ® (pembrolizumab) in Patients with Advanced Solid Tumors.
Computational Fluid Dynamics (CFD) modeling further distinguishes Vapotherm High Velocity Therapy from generic high flow cannulas
Vapotherm, Inc. announced the online publication of “Validation of Human Upper Computational Fluid Dynamics Model for Turbulent Mixing” in the Journal of Fluid Dynamics.